Parallel Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.58M | Buy |
10,183
+96
| +1% | +$34.2K | 0.06% | 203 |
|
|
2025
Q4 | $3.3M | Sell |
10,087
-320
| -3% | -$102K | 0.06% | 211 |
|
|
2025
Q3 | $2.94M | Buy |
10,407
+610
| +6% | +$177K | 0.05% | 221 |
|
|
2025
Q2 | $2.74M | Sell |
9,797
-132
| -1% | -$37.4K | 0.05% | 220 |
|
|
2025
Q1 | $3.09M | Buy |
9,929
+545
| +6% | +$161K | 0.07% | 192 |
|
|
2024
Q4 | $2.45M | Sell |
9,384
-691
| -7% | -$205K | 0.06% | 232 |
|
|
2024
Q3 | $3.25M | Buy |
10,075
+865
| +9% | +$283K | 0.08% | 194 |
|
|
2024
Q2 | $2.88M | Buy |
9,210
+70
| +0.8% | +$20.6K | 0.07% | 194 |
|
|
2024
Q1 | $2.6M | Buy |
9,140
+186
| +2% | +$54.4K | 0.07% | 198 |
|
|
2023
Q4 | $2.58M | Sell |
8,954
-446
| -5% | -$122K | 0.08% | 185 |
|
|
2023
Q3 | $2.53M | Buy |
9,400
+1,055
| +13% | +$263K | 0.08% | 181 |
|
|
2023
Q2 | $1.85M | Sell |
8,345
-1,740
| -17% | -$404K | 0.06% | 216 |
|
|
2023
Q1 | $2.44M | Buy |
10,085
+816
| +9% | +$200K | 0.08% | 176 |
|
|
2022
Q4 | $2.43M | Sell |
9,269
-5
| -0.1% | -$1.34K | 0.11% | 136 |
|
|
2022
Q3 | $2.09M | Buy |
9,274
+409
| +5% | +$99.1K | 0.1% | 142 |
|
|
2022
Q2 | $2.16M | Buy |
8,865
+184
| +2% | +$45.1K | 0.1% | 136 |
|
|
2022
Q1 | $2.11M | Buy |
8,681
+996
| +13% | +$229K | 0.08% | 160 |
|
|
2021
Q4 | $1.73M | Buy |
7,685
+661
| +9% | +$140K | 0.06% | 192 |
|
|
2021
Q3 | $1.49M | Sell |
7,024
-296
| -4% | -$68.1K | 0.06% | 195 |
|
|
2021
Q2 | $1.78M | Sell |
7,320
-75
| -1% | -$18.4K | 0.08% | 176 |
|
|
2021
Q1 | $1.84M | Buy |
7,395
+484
| +7% | +$115K | 0.09% | 164 |
|
|
2020
Q4 | $1.59M | Sell |
6,911
-2,052
| -23% | -$473K | 0.09% | 160 |
|
|
2020
Q3 | $2.28M | Buy |
8,963
+728
| +9% | +$180K | 0.14% | 117 |
|
|
2020
Q2 | $1.94M | Buy |
8,235
+329
| +4% | +$75.1K | 0.13% | 126 |
|
|
2020
Q1 | $1.6M | Sell |
7,906
-708
| -8% | -$155K | 0.13% | 119 |
|
|
2019
Q4 | $2.08M | Buy |
8,614
+488
| +6% | +$108K | 0.16% | 114 |
|
|
2019
Q3 | $1.57M | Buy |
8,126
+863
| +12% | +$166K | 0.13% | 124 |
|
|
2019
Q2 | $1.34M | Sell |
7,263
-55
| -0.8% | -$9.85K | 0.13% | 119 |
|
|
2019
Q1 | $1.39M | Sell |
7,318
-512
| -7% | -$97.8K | 0.16% | 106 |
|
|
2018
Q4 | $1.52M | Sell |
7,830
-29
| -0.4% | -$5.66K | 0.21% | 87 |
|
|
2018
Q3 | $1.63M | Buy |
7,859
+1,599
| +26% | +$315K | 0.2% | 90 |
|
|
2018
Q2 | $1.16M | Buy |
6,260
+1,049
| +20% | +$186K | 0.17% | 106 |
|
|
2018
Q1 | $888K | Sell |
5,211
-193
| -4% | -$35.4K | 0.14% | 117 |
|
|
2017
Q4 | $940K | Sell |
5,404
-42
| -0.8% | -$7.43K | 0.15% | 108 |
|
|
2017
Q3 | $934K | Buy |
5,446
+171
| +3% | +$30.3K | 0.16% | 106 |
|
|
2017
Q2 | $920K | Sell |
5,275
-226
| -4% | -$36.8K | 0.17% | 106 |
|
|
2017
Q1 | $901K | Buy |
5,501
+446
| +9% | +$74.1K | 0.18% | 103 |
|
|
2016
Q4 | $739K | Buy |
+5,055
| New | +$761K | 0.17% | 102 |
|
Other funds holding AMGN
VCM
VPM
Parallel Advisors's AMGN Position: Q1 2026 in Review
Parallel Advisors increased its Amgen (AMGN) stake by 0.95% in Q1 2026, buying an estimated $34.2K and bringing the position to 10,183 shares worth $3.58M. The position accounts for 0.06% of the portfolio, ranked #203.
Parallel Advisors first reported a position in AMGN in Q4 2016 and has held it in 38 quarters since. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Parallel Advisors held 10,183 shares of Amgen worth $3.58M as of Q1 2026.
- Parallel Advisors bought 96 Amgen shares in Q1 2026, an estimated $34.2K.
- Amgen made up 0.06% of Parallel Advisors's portfolio in Q1 2026, its #203 holding.
- Parallel Advisors first reported a position in Amgen in Q4 2016 and has held it in 38 quarters since.
- 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.